Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.
今天上午美國股票期貨小幅走低，道瓊斯指數期貨週三下跌約0.1％。
Shares of Harrow, Inc. (NASDAQ:HROW) fell sharply in today's pre-market trading after posting weaker-than-expected fourth-quarter results.
哈羅公司（納斯達克股票代碼：HROW）公佈的第四季度業績低於預期，股價在今天的盤前交易中大幅下跌。
Harrow Health posted adjusted loss of 20 cents per share, versus market estimates for a loss of 4 cents per share. The company's quarterly sales came in at $36.35 million, missing expectations of $37.86 million, according to data from Benzinga Pro.
哈羅健康公佈調整後的每股虧損爲20美分，而市場預期的每股虧損爲4美分。根據Benzinga Pro的數據，該公司的季度銷售額爲3635萬美元，未達到預期的3,786萬美元。
Harrow shares tumbled 14.6% to $9.09 in pre-market trading.
哈羅股價在盤前交易中下跌14.6％，至9.09美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是一些在今天的盤前交易時段中錄得虧損的大型股票。
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) dipped 14.8% to $4.55 in pre-market trading. Aquestive Therapeutics priced its $75 million underwritten public offering of 16,666,667 common shares at $4.50 per share.
- NuScale Power Corporation (NYSE:SMR) shares dipped 6.8% to $6.13 in pre-market trading. NuScale Power shares dipped around 35% on Tuesday after Wells Fargo downgraded the stock from Equal-Weight to Underweight and lowered its price target from $7.50 to $4.50.
- MaxCyte, Inc. (NASDAQ:MXCT) shares fell 5.8% to $4.20 after gaining 7% on Tuesday. MaxCyte, last week, reported better-than-expected fourth-quarter financial results and issued FY24 guidance.
- TeraWulf Inc. (NASDAQ:WULF) shares declined 4.7% to $1.64 in pre-market trading following downbeat fourth-quarter results.
- MicroStrategy Incorporated (NASDAQ:MSTR) shares fell 3.9% to $1,362.64 in pre-market trading after declining over 5% on Wednesday. MicroStrategy completed $603.75 million offering of 0.875% convertible senior notes due 2031.
- Nasdaq, Inc. (NASDAQ:NDAQ) shares declined 3.1% to $60.52 in pre-market trading. Nasdaq priced secondary offering of 26,956,522 common shares by Borse Dubai at $59 per share.
- Amcor plc (NYSE:AMCR) shares fell 3% to $9.10 in pre-market trading after the company announced CEO transition and reaffirmed fiscal 2024 forecast.
- Aquestive Therapeutics, Inc.（納斯達克股票代碼：AQST）在盤前交易中下跌14.8％，至4.55美元。Aquestive Therapeutics將其承銷的16,666,667股普通股的7500萬美元公開發行定價爲每股4.50美元。
- NuScale Power Corporation（紐約證券交易所代碼：SMR）股價在盤前交易中下跌6.8％，至6.13美元。週二，富國銀行將該股的評級從等權下調至減持，並將目標股價從7.50美元下調至4.50美元，此後，NuScale Power股價週二下跌了約35％。
- MaxCyte, Inc.（納斯達克股票代碼：MXCT）股價在週二上漲7％後下跌5.8％，至4.20美元。MaxCyte上週公佈的第四季度財務業績好於預期，併發布了24財年指引。
- 在第四季度業績不佳之後，TeraWulf Inc.（納斯達克股票代碼：WULF）股價在盤前交易中下跌4.7％，至1.64美元。
- 微策略公司（納斯達克股票代碼：MSTR）股價在週三下跌超過5％後，在盤前交易中下跌3.9％，至1,362.64美元。MicroStrategy完成了6.0375億美元的0.875％可轉換優先票據的發行，2031年到期。
- 納斯達克公司（納斯達克股票代碼：NDAQ）股價在盤前交易中下跌3.1％，至60.52美元。納斯達克將迪拜證券交易所二次發行的26,956,522股普通股定價爲每股59美元。
- 安姆科公司（紐約證券交易所代碼：AMCR）的股價在盤前交易中下跌了3％，至9.10美元，此前該公司宣佈首席執行官過渡並重申了2024財年的預測。
Now Read This: Fear & Greed Index Remains In 'Greed' Zone Ahead Of Fed's Interest Rate Decision
現在讀這個： 在聯儲局做出利率決定之前，恐懼與貪婪指數仍處於 “貪婪” 區域
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
譯文內容由第三人軟體翻譯。